论文部分内容阅读
目的:观察通气散方联合布地奈德鼓室注射治疗分泌性中耳炎临床疗效。方法:将分泌性中耳炎患者90例按随机数字表法分为2组各45例。对照组采用布地奈德鼓室注射治疗,观察组联合通气散方治疗,比较2组临床疗效及药物安全性。结果:治疗后,2组不同频率下气导听力出现下降趋势,观察组治疗后0.5 k Hz、1 k Hz及2 k Hz下气导听力低于对照组(P<0.05)。观察组治疗后听力指标鼓室压及语频气导听阀指标改善优于对照组(P<0.05)。治疗后观察组不良反应发生率为4.44%,对照组为13.33%,2组比较,差异有统计学意义(P<0.05)。结论:在布地奈德鼓室注射治疗基础上联合通气散方治疗分泌性中耳炎疗效好且安全。
Objective: To observe the clinical effect of ventilation combined with budesonide tympanum injection in the treatment of secretory otitis media. Methods: 90 cases of secretory otitis media were randomly divided into two groups of 45 cases. The control group was treated with budesonide tympanic injection, and the observation group was treated with ventilation group. The clinical efficacy and drug safety were compared between the two groups. Results: After treatment, the air conduction hearing decreased at two different frequencies. The air conduction hearing at 0.5 k Hz, 1 k Hz and 2 k Hz in the observation group was lower than that in the control group (P <0.05). The improvement of tympanic pressure and audiocode valve index in observation group after treatment was better than that in control group (P <0.05). After treatment, the incidence of adverse reactions was 4.44% in the observation group and 13.33% in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Budesonide tympanum injection therapy based on the combined ventilation of the treatment of secretory otitis media is effective and safe.